Literature DB >> 10328254

Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians.

E von Strauss1, M Viitanen, D De Ronchi, B Winblad, L Fratiglioni.   

Abstract

CONTEXT: In spite of numerous studies on the occurrence of dementia, many questions remain, such as the relation between age, aging, and dementing disorders. This question is relevant both for understanding the pathogenetic mechanism of the dementias and for the public health prospective because of the increasing number of 85-year-old or older persons in our population.
OBJECTIVE: To estimate the occurrence of dementia in the very old, including nonagenarians, in relation to age, gender, and different dementia types.
DESIGN: An epidemiological survey where all participants were clinically examined by physicians, assessed by psychologists, and interviewed by nurses. The Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition (DSM-III-R) criteria for dementia were followed. A category of "questionable dementia" was added when all criteria were not fulfilled. A double diagnostic procedure was used for all subjects.
SETTING: Community-based population, including all inhabitants of 2 areas in central Stockholm, Sweden (N = 1848). PARTICIPANTS: Of the 1848 subjects in the study population, 168 (9.1%) had died and 56 (3%) moved before examination. Of the remaining subjects, 1424 (87.7%) were examined, and the refusal rate was 12.3%. MAIN OUTCOME MEASURES: Age- and gender-specific prevalence figures, and gender- and education-adjusted odds ratios were used.
RESULTS: At the end of the diagnostic procedure, 358 clinically definite cases of dementia and 101 questionable cases of dementia were identified. Alzheimer disease (AD) contributed to 76.5%, and vascular dementia (VaD) to 17.9%. The prevalence of dementia increases from 13% in the 77- to 84-year-old subjects to 48% among persons 95 years and older (from 18% to 61% when questionable cases were included). The odds ratio for subjects 90 to 94 years and 95 years and older in comparison with 77- to 84-year-old subjects was 3.7 (95% confidence interval [CI], 2.7-5.1) and 6.5 (95% CI, 3.9-10.8) for dementia, 4.8 (95% CI, 3.3-7.0) and 8.0 (95% CI, 4.6-14.0) for persons with AD, 2.3 (95% CI, 1.3-4.2) and 4.6 (95% CI, 1.9-11.2) for VaD, respectively.
CONCLUSIONS: Dementia prevalence continues to increase even in the most advanced ages. This increase is especially evident among women and is more clear for AD. We believe that our prevalence data reflect the differential distribution of dementia risk.

Entities:  

Mesh:

Year:  1999        PMID: 10328254     DOI: 10.1001/archneur.56.5.587

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  57 in total

1.  Understanding dementia prevalence among centenarians.

Authors:  Leonard W Poon; John L Woodard; L Stephen Miller; Robert Green; Marla Gearing; Adam Davey; Jonathan Arnold; Peter Martin; Ilene C Siegler; Lusine Nahapetyan; Young Sek Kim; William Markesbery
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-01       Impact factor: 6.053

Review 2.  Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations.

Authors:  Christiane Reitz
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

3.  Distinct profiles of brain and cognitive changes in the very old with Alzheimer disease.

Authors:  N H Stricker; Y-L Chang; C Fennema-Notestine; L Delano-Wood; D P Salmon; M W Bondi; A M Dale
Journal:  Neurology       Date:  2011-08-10       Impact factor: 9.910

Review 4.  End-of-life considerations in older patients who have lung disease.

Authors:  Renee D Stapleton; J Randall Curtis
Journal:  Clin Chest Med       Date:  2007-12       Impact factor: 2.878

5.  Physical activity and risk of cognitive impairment among oldest-old women.

Authors:  Sophia Wang; Xiaodong Luo; Deborah Barnes; Mary Sano; Kristine Yaffe
Journal:  Am J Geriatr Psychiatry       Date:  2013-07-03       Impact factor: 4.105

6.  Lifespan profiles of Alzheimer's disease-associated genes and products in monkeys and mice.

Authors:  Remi Dosunmu; Jinfang Wu; Lina Adwan; Bryan Maloney; Md Riyaz Basha; Christopher A McPherson; G Jean Harry; Deborah C Rice; Nasser H Zawia; Debomoy K Lahiri
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

7.  Gene expression changes in the course of normal brain aging are sexually dimorphic.

Authors:  Nicole C Berchtold; David H Cribbs; Paul D Coleman; Joseph Rogers; Elizabeth Head; Ronald Kim; Tom Beach; Carol Miller; Juan Troncoso; John Q Trojanowski; H Ronald Zielke; Carl W Cotman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-01       Impact factor: 11.205

Review 8.  Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1.

Authors:  Richard Mayeux; Christiane Reitz; Adam M Brickman; Mary N Haan; Jennifer J Manly; M Maria Glymour; Christopher C Weiss; Kristine Yaffe; Laura Middleton; Hugh C Hendrie; Lauren H Warren; Kathleen M Hayden; Kathleen A Welsh-Bohmer; John C S Breitner; John C Morris
Journal:  Alzheimers Dement       Date:  2011-01       Impact factor: 21.566

Review 9.  Memantine: a pharmacoeconomic review of its use in moderate-to-severe Alzheimer's disease.

Authors:  Greg L Plosker; Katherine A Lyseng-Williamson
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 10.  Dyslipidemia and the risk of Alzheimer's disease.

Authors:  Christiane Reitz
Journal:  Curr Atheroscler Rep       Date:  2013-03       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.